By Novo Nordisk
US | Published September 06, 2019
For the last several months, we’ve talked to many people within the diabetes community and asked, “What more can we do?” based on the healthcare system Americans rely on today. These people face different challenges and situations and one solution can’t cover them all. While we continue to work with others in the US healthcare system for a longer-term solution, we feel the sense of urgency and anger from the community and want to do more both for those who have insurance and those who do not.
So, in addition to Novo Nordisk’s current affordability options on NovoCare.com—including our Patient Assistance Programs that can offer free medicines to eligible patients, Novo Nordisk human insulin which has been available for $25/vial at Walmart and recently expanded to CVS Health and ESI, and our co-pay savings cards—Novo Nordisk will offer two additional options on January 2, 2020:
More details are found in our press release and more specific details will be available at the time these offerings are launched. We believe these offerings represent helpful additions to our NovoCare® affordability program, especially for people with diabetes in high-deductible health plans or without insurance.
Although we hope this is a meaningful step, we recognize that it’s not the answer for everyone. We’ll continue to work toward longer-term reform and making it easier for people who need our help to get it. For instance, we support the recent IRS ruling that classifies diabetes medications as preventive care. This has the potential to help so many people with diabetes. We are actively requesting that insurance plan decision makers participate in this new rule.
In the meantime, anyone who needs help affording our medicines should visit NovoCare.com for information about our Patient Assistance Programs, co-pay cards, and more, or call our Customer Care team at 1.800.727.6500.
We use Facebook as our commenting platform. By entering your comment above you acknowledge that the information you post will not only be subject to Novo Nordisk community guidelines but will be posted on Facebook in accordance with their Terms of Service and Data Policy and subject to their Community Standards.